The Filing Desk

CareCloud

CCLD · Nasdaq · Health Care · Financials, fiscal 2016 to 2025

CCLD · Last close · November 19, 2026
$2.32
Value CareCloud yourself

CareCloud's revenue rose 8.7% to $120 million in fiscal 2025. Its operating margin was 9.4%, up from 8.2% a year earlier. Free cash flow was $24 million, up 25.5%. The diluted share count rose 135.1%.

CareCloud, Inc. Latest fiscal year ended December 31, 2025 10-K filed March 12, 2026 · 0001493152-26-009872 Updated
Revenue
$120M
8.7%
Operating margin
9.4%
1.2 pts
Net income
$11M
37.5%
Free cash flow
$24M
25.5%
Return on capital
21.5%
2.6 pts
Market cap
$99M
Nov 19 close
P/E
19.3x
On $0.12 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What CareCloud does

CareCloud sells software and back-office services to US doctors' practices, medical groups, hospitals and health systems. Its main service is revenue cycle management: handling a provider's medical billing, coding and insurance claims so it gets paid. It also sells cloud-based electronic health records and practice management software, tools that use artificial intelligence to draft insurance appeals and answer patient calls, remote patient monitoring and telemedicine, and IT consulting and temporary staff for health systems.

It reports two segments. Healthcare IT holds the billing services, usually charged as a percentage of the payments a client collects, with the client's use of CareCloud's software included in the fee; these accounted for about 63% of revenue in 2025. Medical Practice Management, where CareCloud runs practices' offices, staff and supplies for a fee, brought in about 12%. It competes with other billing, practice management and health records providers, including regional billing firms, and with large health systems that do this work themselves.

Most of its work, from software development to customer support and billing, is done by about 3,300 employees in offices abroad, about 98% of them in Pakistan and the rest in Sri Lanka. CareCloud has grown by buying other companies, recently including Medsphere, MAP App and RevNu Medical Management.

Its biggest risks, as it describes them

  • Its reliance on its offices in Pakistan, where unrest, sanctions or other disruptions could raise its costs or stop its work.
  • Software or service platforms, including ones it bought, failing to work properly, which could bring claims or cost it clients.
  • Failing to keep the clients and revenue of the businesses it buys, or to integrate them well.
  • Strong competition, including from large health systems that bring billing work in-house.
  • Breaking the many healthcare, privacy and billing laws that apply to its work for providers.
From CareCloud's annual report on Form 10-K, filed March 12, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow
Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments912353
Debt incl. finance leases991112
Net debt (negative means net cash)−1−47−4−1
Net debt to EBITDA−0.0x−0.2x—−0.2x−0.1x
Debt to equity0.1x0.1x0.2x0.0x0.0x
Interest coverage34.3x40.8x−50.8x13.5x50.2x
Current ratio1.2x1.6x1.0x1.3x1.1x
Quick ratio1.2x1.5x1.0x1.2x1.0x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project CareCloud's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What CareCloud says to expect

  • Calendar year 2026: GAAP earnings per shareGAAP EPS guidance of $0.20–$0.23 represents a 100-130% increase from the $0.10 achieved in full year 2025.
  • Calendar year 2026: adjusted EBITDAAdjusted EBITDA guidance of $29–$31 million represents growth of approximately 5–13% over 2025 actuals of $27.5 million.
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 5, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

No officer, director or 10% owner of CareCloud reported buying or selling its shares on the open market between November 20, 2025 and November 19, 2026.

From Form 4 filings with the SEC. Grants, option exercises and shares withheld for tax aren't counted. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score2 of 87 of 85 of 8
Rule of 40−5.1%11.8%28.4%
Altman Z''−5.980.691.11
Accruals ratio−59.9%−17.1%−22.3%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailPassPass
Cash from operations is positivePassPassPass
Return on assets roseFailPassPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsFailPassFail
Current ratio roseFailPassFail
Share count didn't riseFailFailFail
Gross margin rose———
Revenue rose relative to assetsFailPassPass
F-score2 of 87 of 85 of 8
Companies that report no gross profit are scored on the other eight.

Compare

Put CareCloud side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
CareCloudFY258.7%9.4%19.7%21.5%−0.1x5
OptimizeRxFY2518.8%10.7%17.1%6.4%0.2x8Compare
NRC HealthFY25−4.0%16.4%11.5%16.4%2.5x5Compare
HeartFlowFY2539.9%−36.4%−33.5%———Compare
SOPHiA GENETICSFY2518.6%−91.8%−47.2%−207.1%—2Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue24325064105140139117111120
Revenue growth6.1%29.9%58.9%27.5%63.1%32.8%−0.6%−15.7%−5.3%8.7%
Gross profit——————————
Research and development1111944546
Operating income−8−4−20−847−47911
Net income−9−6−2−1−935−49811
Diluted EPS (US$)−0.95−0.69−0.59−0.60−1.79−0.77−0.67−4.11−0.280.10
Diluted shares (millions)10111212131415161638
Cash flow
Cash from operations−1078−11321162129
Capital expenditure0112333325
Free cash flow−1−066−31019121924
Dividends paid0000000000
Share buybacks0000000000
Acquisitions30132241300016
Stock-based compensation2223655500
Balance sheet at fiscal year end
Cash and short-term investments44142021912353
Debt incl. finance leases70111991112
Total assets28264856138141136787288
Total liabilities215914374334362228
Shareholders' equity720394310198102425060
Margins and ratios
Gross margin——————————
Operating margin−32.3%−14.2%−5.0%0.1%−7.9%2.5%4.8%−40.2%8.2%9.4%
Net margin−35.9%−17.5%−4.2%−1.4%−8.4%2.0%3.9%−41.6%7.1%9.0%
Free cash flow margin−5.5%−1.3%11.4%8.7%−3.3%7.5%13.4%10.6%17.1%19.7%
Rule of 40 (growth + FCF margin)0.6%28.6%70.3%36.2%59.8%40.2%12.8%−5.1%11.8%28.4%
Return on capital−55.5%−26.8%−9.7%0.2%−12.5%3.8%6.5%−50.6%19.0%21.5%
Return on equity−80.1%−40.7%−7.2%−2.1%−12.2%2.9%5.4%−67.9%17.2%19.8%
Return on assets−32.0%−20.7%−5.8%−1.7%−9.1%2.0%3.9%−45.5%10.5%13.6%
Net debt to EBITDA——−43.6x−6.3x−12.3x−0.0x−0.2x—−0.2x−0.1x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: CareCloud's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with CareCloud.